APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Precision Medicine

According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.

Selected research

Market Analysis & Forecast

Global Precision Medicine Market Analysis and Forecast 2026-2032

Report ID 173895310226 December 2025201 pages

Choose your research edition.

Industry ResearchPrecision Medicine Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Precision Medicine Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Precision Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Precision Medicine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Precision Medicine Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.

The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.

Read the full market overview

Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.

Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.

Report Includes

This report presents an overview of global market for Precision Medicine, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Precision Medicine, also provides the revenue of main regions and countries. Of the upcoming market potential for Precision Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Precision Medicine revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Precision Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Precision Medicine revenue, projected growth trends, production technology, application and end-user industry.

Precision Medicine Segment by Company

Johnson & Johnson

Roche

Labcorp

Abbott Laboratories

Novartis

Illumina

GE Healthcare

Intel Corporation

Biomrieux Sa

Cepheid

IBM

Qiagen

Thermo Fisher Scientific

Randox Laboratories

Almac Group

Healthcore

Precision Medicine Segment by Type

Diagnostics

Therapies

Precision Medicine Segment by Application

Oncology

Neurosciences

Immunology

Respiratory

Others

Precision Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Precision Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Precision Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Precision Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Precision Medicine revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Precision Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Diagnostics Major Player Table 3. Therapies Major Player Table 4. Global Precision Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Oncology Major Player Table 6. Neurosciences Major Player Table 7. Immunology Major Player Table 8. Respiratory Major Player Table 9. Others Major Player Table 10. Precision Medicine Industry Trends Table 11. Precision Medicine Industry Drivers Table 12. Precision Medicine Industry Opportunities and Challenges Table 13. Precision Medicine Industry Restraints Table 14. Global Precision Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Precision Medicine Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Precision Medicine Market Share by Region (2021-2026) Table 17. Global Precision Medicine Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Precision Medicine Market Share by Region (2027-2032) Table 19. Global Precision Medicine Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Precision Medicine Revenue Market Share by Players (2021-2026) Table 21. Global Precision Medicine Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Precision Medicine Key Players Headquarters & Area Served Table 23. Global Precision Medicine Players, Product Type & Application Table 24. Global Precision Medicine Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Precision Medicine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Precision Medicine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Precision Medicine Revenue Market Share by Type (2021-2026) Table 31. Global Precision Medicine Revenue Market Share by Type (2027-2032) Table 32. Global Precision Medicine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Precision Medicine Revenue Market Share by Application (2021-2026) Table 36. Global Precision Medicine Revenue Market Share by Application (2027-2032) Table 37. Johnson & Johnson Company Information Table 38. Johnson & Johnson Business Overview Table 39. Johnson & Johnson Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Johnson & Johnson Precision Medicine Product Portfolio Table 41. Johnson & Johnson Recent Development Table 42. Roche Company Information Table 43. Roche Business Overview Table 44. Roche Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Roche Precision Medicine Product Portfolio Table 46. Roche Recent Development Table 47. Labcorp Company Information Table 48. Labcorp Business Overview Table 49. Labcorp Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Labcorp Precision Medicine Product Portfolio Table 51. Labcorp Recent Development Table 52. Abbott Laboratories Company Information Table 53. Abbott Laboratories Business Overview Table 54. Abbott Laboratories Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Abbott Laboratories Precision Medicine Product Portfolio Table 56. Abbott Laboratories Recent Development Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Novartis Precision Medicine Product Portfolio Table 61. Novartis Recent Development Table 62. Illumina Company Information Table 63. Illumina Business Overview Table 64. Illumina Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Illumina Precision Medicine Product Portfolio Table 66. Illumina Recent Development Table 67. GE Healthcare Company Information Table 68. GE Healthcare Business Overview Table 69. GE Healthcare Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. GE Healthcare Precision Medicine Product Portfolio Table 71. GE Healthcare Recent Development Table 72. Intel Corporation Company Information Table 73. Intel Corporation Business Overview Table 74. Intel Corporation Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Intel Corporation Precision Medicine Product Portfolio Table 76. Intel Corporation Recent Development Table 77. Biomrieux Sa Company Information Table 78. Biomrieux Sa Business Overview Table 79. Biomrieux Sa Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Biomrieux Sa Precision Medicine Product Portfolio Table 81. Biomrieux Sa Recent Development Table 82. Cepheid Company Information Table 83. Cepheid Business Overview Table 84. Cepheid Precision Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Cepheid Precision Medicine Product Portfolio Table 86. Cepheid Recent Development Table 87. IBM Company Information Table 88. IBM Business Overview Table 89. IBM Precision Medicine Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 90. IBM Precision Medicine Product Portfolio Table 91. IBM Recent Development Table 92. Qiagen Company Information Table 93. Qiagen Business Overview Table 94. Qiagen Precision Medicine Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 95. Qiagen Precision Medicine Product Portfolio Table 96. Qiagen Recent Development Table 97. Thermo Fisher Scientific Company Information Table 98. Thermo Fisher Scientific Business Overview Table 99. Thermo Fisher Scientific Precision Medicine Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 100. Thermo Fisher Scientific Precision Medicine Product Portfolio Table 101. Thermo Fisher Scientific Recent Development Table 102. Randox Laboratories Company Information Table 103. Randox Laboratories Business Overview Table 104. Randox Laboratories Precision Medicine Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 105. Randox Laboratories Precision Medicine Product Portfolio Table 106. Randox Laboratories Recent Development Table 107. Almac Group Company Information Table 108. Almac Group Business Overview Table 109. Almac Group Precision Medicine Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 110. Almac Group Precision Medicine Product Portfolio Table 111. Almac Group Recent Development Table 112. Healthcore Company Information Table 113. Healthcore Business Overview Table 114. Healthcore Precision Medicine Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 115. Healthcore Precision Medicine Product Portfolio Table 116. Healthcore Recent Development Table 117. North America Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Precision Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Precision Medicine Revenue by Country (2021-2026) & (US$ Million) Table 123. North America Precision Medicine Revenue by Country (US$ Million) & (2027-2032) Table 124. Europe Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Precision Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Precision Medicine Revenue by Country (2021-2026) & (US$ Million) Table 130. Europe Precision Medicine Revenue by Country (US$ Million) & (2027-2032) Table 131. China Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 132. China Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 133. China Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 134. China Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Precision Medicine Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Precision Medicine Revenue by Region (US$ Million) & (2021-2026) Table 141. Asia Precision Medicine Revenue by Region (US$ Million) & (2027-2032) Table 142. SAMEA Precision Medicine Revenue by Type (2021-2026) & (US$ Million) Table 143. SAMEA Precision Medicine Revenue by Type (2027-2032) & (US$ Million) Table 144. SAMEA Precision Medicine Revenue by Application (2021-2026) & (US$ Million) Table 145. SAMEA Precision Medicine Revenue by Application (2027-2032) & (US$ Million) Table 146. SAMEA Precision Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. SAMEA Precision Medicine Revenue by Country (2021-2026) & (US$ Million) Table 148. SAMEA Precision Medicine Revenue by Country (US$ Million) & (2027-2032) Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Precision Medicine Image Figure 2. Global Precision Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Precision Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Diagnostics Image Figure 5. Therapies Image Figure 6. Global Precision Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Precision Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Oncology Image Figure 9. Neurosciences Image Figure 10. Immunology Image Figure 11. Respiratory Image Figure 12. Others Image Figure 13. Global Precision Medicine Market Size (US$ Million) & (2021-2032) Figure 14. Global Precision Medicine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Precision Medicine Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Precision Medicine Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Precision Medicine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Precision Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Precision Medicine Revenue Market Share by Type (2021-2032) Figure 21. Global Precision Medicine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Precision Medicine Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Precision Medicine Revenue Market Share by Application (2021-2032) Figure 24. North America Precision Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Precision Medicine Revenue Share by Type (2021-2032) Figure 26. North America Precision Medicine Revenue Share by Application (2021-2032) Figure 27. North America Precision Medicine Revenue Share by Country (2021-2032) Figure 28. United States Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Precision Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Precision Medicine Revenue Share by Type (2021-2032) Figure 33. Europe Precision Medicine Revenue Share by Application (2021-2032) Figure 34. Europe Precision Medicine Revenue Share by Country (2021-2032) Figure 35. Germany Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Precision Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Precision Medicine Revenue Share by Type (2021-2032) Figure 45. China Precision Medicine Revenue Share by Application (2021-2032) Figure 46. Asia Precision Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Precision Medicine Revenue Share by Type (2021-2032) Figure 48. Asia Precision Medicine Revenue Share by Application (2021-2032) Figure 49. Asia Precision Medicine Revenue Share by Region (2021-2032) Figure 50. Japan Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Precision Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Precision Medicine Revenue Share by Type (2021-2032) Figure 58. SAMEA Precision Medicine Revenue Share by Application (2021-2032) Figure 59. SAMEA Precision Medicine Revenue Share by Country (2021-2032) Figure 60. Brazil Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Precision Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostics
  • Therapies
Applications
  • Oncology
  • Neurosciences
  • Immunology
  • Respiratory
  • Others
Companies covered
  • Johnson & Johnson
  • Roche
  • Labcorp
  • Abbott Laboratories
  • Novartis
  • Illumina
  • GE Healthcare
  • Intel Corporation
  • Biomrieux Sa
  • Cepheid
  • IBM
  • Qiagen
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Almac Group
  • Healthcore

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Precision Medicine Market by Type
  3. 1.2.1 Global Precision Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Diagnostics
  5. 1.2.3 Therapies
  6. 1.3 Precision Medicine Market by Application
  7. 1.3.1 Global Precision Medicine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Oncology
  9. 1.3.3 Neurosciences
  10. 1.3.4 Immunology
  11. 1.3.5 Respiratory
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Precision Medicine Market Dynamics
  1. 2.1 Precision Medicine Industry Trends
  2. 2.2 Precision Medicine Industry Drivers
  3. 2.3 Precision Medicine Industry Opportunities and Challenges
  4. 2.4 Precision Medicine Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Precision Medicine Market Perspective (2021-2032)
  2. 3.2 Global Precision Medicine Growth Trends by Region
  3. 3.2.1 Global Precision Medicine Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Precision Medicine Market Size by Region (2021-2026)
  5. 3.2.3 Global Precision Medicine Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Precision Medicine Revenue by Players
  2. 4.1.1 Global Precision Medicine Revenue by Players (2021-2026)
  3. 4.1.2 Global Precision Medicine Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Precision Medicine Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Precision Medicine Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Precision Medicine Key Players Headquarters & Area Served
  7. 4.4 Global Precision Medicine Players, Product Type & Application
  8. 4.5 Global Precision Medicine Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Precision Medicine Market CR5 and HHI
  11. 4.6.3 2025 Precision Medicine Tier 1, Tier 2, and Tier 3
5 Precision Medicine Market Size by Type
  1. 5.1 Global Precision Medicine Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Precision Medicine Revenue by Type (2021-2032)
  3. 5.3 Global Precision Medicine Revenue Market Share by Type (2021-2032)
6 Precision Medicine Market Size by Application
  1. 6.1 Global Precision Medicine Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Precision Medicine Revenue by Application (2021-2032)
  3. 6.3 Global Precision Medicine Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Precision Medicine Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Precision Medicine Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Roche
  8. 7.2.1 Roche Company Information
  9. 7.2.2 Roche Business Overview
  10. 7.2.3 Roche Precision Medicine Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Roche Precision Medicine Product Portfolio
  12. 7.2.5 Roche Recent Developments
  13. 7.3 Labcorp
  14. 7.3.1 Labcorp Company Information
  15. 7.3.2 Labcorp Business Overview
  16. 7.3.3 Labcorp Precision Medicine Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Labcorp Precision Medicine Product Portfolio
  18. 7.3.5 Labcorp Recent Developments
  19. 7.4 Abbott Laboratories
  20. 7.4.1 Abbott Laboratories Company Information
  21. 7.4.2 Abbott Laboratories Business Overview
  22. 7.4.3 Abbott Laboratories Precision Medicine Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Abbott Laboratories Precision Medicine Product Portfolio
  24. 7.4.5 Abbott Laboratories Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Precision Medicine Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Precision Medicine Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Illumina
  32. 7.6.1 Illumina Company Information
  33. 7.6.2 Illumina Business Overview
  34. 7.6.3 Illumina Precision Medicine Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Illumina Precision Medicine Product Portfolio
  36. 7.6.5 Illumina Recent Developments
  37. 7.7 GE Healthcare
  38. 7.7.1 GE Healthcare Company Information
  39. 7.7.2 GE Healthcare Business Overview
  40. 7.7.3 GE Healthcare Precision Medicine Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GE Healthcare Precision Medicine Product Portfolio
  42. 7.7.5 GE Healthcare Recent Developments
  43. 7.8 Intel Corporation
  44. 7.8.1 Intel Corporation Company Information
  45. 7.8.2 Intel Corporation Business Overview
  46. 7.8.3 Intel Corporation Precision Medicine Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Intel Corporation Precision Medicine Product Portfolio
  48. 7.8.5 Intel Corporation Recent Developments
  49. 7.9 Biomrieux Sa
  50. 7.9.1 Biomrieux Sa Company Information
  51. 7.9.2 Biomrieux Sa Business Overview
  52. 7.9.3 Biomrieux Sa Precision Medicine Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Biomrieux Sa Precision Medicine Product Portfolio
  54. 7.9.5 Biomrieux Sa Recent Developments
  55. 7.10 Cepheid
  56. 7.10.1 Cepheid Company Information
  57. 7.10.2 Cepheid Business Overview
  58. 7.10.3 Cepheid Precision Medicine Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Cepheid Precision Medicine Product Portfolio
  60. 7.10.5 Cepheid Recent Developments
  61. 7.11 IBM
  62. 7.11.1 IBM Company Information
  63. 7.11.2 IBM Business Overview
  64. 7.11.3 IBM Precision Medicine Revenue and Gross Margin (2021-2026)
  65. 7.11.4 IBM Precision Medicine Product Portfolio
  66. 7.11.5 IBM Recent Developments
  67. 7.12 Qiagen
  68. 7.12.1 Qiagen Company Information
  69. 7.12.2 Qiagen Business Overview
  70. 7.12.3 Qiagen Precision Medicine Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Qiagen Precision Medicine Product Portfolio
  72. 7.12.5 Qiagen Recent Developments
  73. 7.13 Thermo Fisher Scientific
  74. 7.13.1 Thermo Fisher Scientific Company Information
  75. 7.13.2 Thermo Fisher Scientific Business Overview
  76. 7.13.3 Thermo Fisher Scientific Precision Medicine Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Thermo Fisher Scientific Precision Medicine Product Portfolio
  78. 7.13.5 Thermo Fisher Scientific Recent Developments
  79. 7.14 Randox Laboratories
  80. 7.14.1 Randox Laboratories Company Information
  81. 7.14.2 Randox Laboratories Business Overview
  82. 7.14.3 Randox Laboratories Precision Medicine Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Randox Laboratories Precision Medicine Product Portfolio
  84. 7.14.5 Randox Laboratories Recent Developments
  85. 7.15 Almac Group
  86. 7.15.1 Almac Group Company Information
  87. 7.15.2 Almac Group Business Overview
  88. 7.15.3 Almac Group Precision Medicine Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Almac Group Precision Medicine Product Portfolio
  90. 7.15.5 Almac Group Recent Developments
  91. 7.16 Healthcore
  92. 7.16.1 Healthcore Company Information
  93. 7.16.2 Healthcore Business Overview
  94. 7.16.3 Healthcore Precision Medicine Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Healthcore Precision Medicine Product Portfolio
  96. 7.16.5 Healthcore Recent Developments
8 North America
  1. 8.1 North America Precision Medicine Revenue (2021-2032)
  2. 8.2 North America Precision Medicine Revenue by Type (2021-2032)
  3. 8.2.1 North America Precision Medicine Revenue by Type (2021-2026)
  4. 8.2.2 North America Precision Medicine Revenue by Type (2027-2032)
  5. 8.3 North America Precision Medicine Revenue Share by Type (2021-2032)
  6. 8.4 North America Precision Medicine Revenue by Application (2021-2032)
  7. 8.4.1 North America Precision Medicine Revenue by Application (2021-2026)
  8. 8.4.2 North America Precision Medicine Revenue by Application (2027-2032)
  9. 8.5 North America Precision Medicine Revenue Share by Application (2021-2032)
  10. 8.6 North America Precision Medicine Revenue by Country
  11. 8.6.1 North America Precision Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Precision Medicine Revenue by Country (2021-2026)
  13. 8.6.3 North America Precision Medicine Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Precision Medicine Revenue (2021-2032)
  2. 9.2 Europe Precision Medicine Revenue by Type (2021-2032)
  3. 9.2.1 Europe Precision Medicine Revenue by Type (2021-2026)
  4. 9.2.2 Europe Precision Medicine Revenue by Type (2027-2032)
  5. 9.3 Europe Precision Medicine Revenue Share by Type (2021-2032)
  6. 9.4 Europe Precision Medicine Revenue by Application (2021-2032)
  7. 9.4.1 Europe Precision Medicine Revenue by Application (2021-2026)
  8. 9.4.2 Europe Precision Medicine Revenue by Application (2027-2032)
  9. 9.5 Europe Precision Medicine Revenue Share by Application (2021-2032)
  10. 9.6 Europe Precision Medicine Revenue by Country
  11. 9.6.1 Europe Precision Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Precision Medicine Revenue by Country (2021-2026)
  13. 9.6.3 Europe Precision Medicine Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Precision Medicine Revenue (2021-2032)
  2. 10.2 China Precision Medicine Revenue by Type (2021-2032)
  3. 10.2.1 China Precision Medicine Revenue by Type (2021-2026)
  4. 10.2.2 China Precision Medicine Revenue by Type (2027-2032)
  5. 10.3 China Precision Medicine Revenue Share by Type (2021-2032)
  6. 10.4 China Precision Medicine Revenue by Application (2021-2032)
  7. 10.4.1 China Precision Medicine Revenue by Application (2021-2026)
  8. 10.4.2 China Precision Medicine Revenue by Application (2027-2032)
  9. 10.5 China Precision Medicine Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Precision Medicine Revenue (2021-2032)
  2. 11.2 Asia Precision Medicine Revenue by Type (2021-2032)
  3. 11.2.1 Asia Precision Medicine Revenue by Type (2021-2026)
  4. 11.2.2 Asia Precision Medicine Revenue by Type (2027-2032)
  5. 11.3 Asia Precision Medicine Revenue Share by Type (2021-2032)
  6. 11.4 Asia Precision Medicine Revenue by Application (2021-2032)
  7. 11.4.1 Asia Precision Medicine Revenue by Application (2021-2026)
  8. 11.4.2 Asia Precision Medicine Revenue by Application (2027-2032)
  9. 11.5 Asia Precision Medicine Revenue Share by Application (2021-2032)
  10. 11.6 Asia Precision Medicine Revenue by Country
  11. 11.6.1 Asia Precision Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Precision Medicine Revenue by Country (2021-2026)
  13. 11.6.3 Asia Precision Medicine Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Precision Medicine Revenue (2021-2032)
  2. 12.2 SAMEA Precision Medicine Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Precision Medicine Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Precision Medicine Revenue by Type (2027-2032)
  5. 12.3 SAMEA Precision Medicine Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Precision Medicine Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Precision Medicine Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Precision Medicine Revenue by Application (2027-2032)
  9. 12.5 SAMEA Precision Medicine Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Precision Medicine Revenue by Country
  11. 12.6.1 SAMEA Precision Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Precision Medicine Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Precision Medicine Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst